Literature DB >> 18771451

Elevated C-reactive protein is related to cognitive decline in older adults with cardiovascular disease.

Karin F Hoth1, Andreana P Haley, John Gunstad, Robert H Paul, Athena Poppas, Angela L Jefferson, David F Tate, Makoto Ono, Beth A Jerskey, Ronald A Cohen.   

Abstract

OBJECTIVES: To prospectively relate C-reactive protein (CRP), a systemic marker of inflammation, to cognitive change over a 1-year follow-up period.
DESIGN: Prospective 1-year follow-up.
SETTING: Outpatient university medical setting. PARTICIPANTS: Seventy-eight adults (aged 56-84; 39% female) with cardiovascular disease. MEASUREMENTS: CRP levels were measured using a high-sensitivity assay, and participants completed a neuropsychological battery at study entry. Neuropsychological assessment was repeated 1 year later.
RESULTS: The association between CRP and change in cognition over the 1-year follow-up was examined using hierarchical linear regression modeling for five cognitive domains (global cognition, language, memory, visuospatial abilities, and attention-executive-psychomotor). High CRP levels were associated with subtle declines in attention-executive-psychomotor performance (CRP beta=-0.22, P=.04) after adjusting for the effects of age and cognitive performance at study entry. CRP was not significantly associated with change in language, memory, or visuospatial performance.
CONCLUSION: These data provide preliminary evidence that inflammation, potentially contributing to atherosclerotic processes, may underlie the association between high CRP and changes in attention-executive-psychomotor performance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18771451      PMCID: PMC2704859          DOI: 10.1111/j.1532-5415.2008.01930.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  19 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

3.  Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging.

Authors:  Giovanni Ravaglia; Paola Forti; Fabiola Maioli; Martina Chiappelli; Fausta Montesi; Emanuela Tumini; Erminia Mariani; Federico Licastro; Christopher Patterson
Journal:  Neurobiol Aging       Date:  2006-09-29       Impact factor: 4.673

4.  Executive dysfunction in subcortical ischaemic vascular disease.

Authors:  J H Kramer; B R Reed; D Mungas; M W Weiner; H C Chui
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

5.  Serum inflammatory proteins and cognitive decline in older persons.

Authors:  M G Dik; C Jonker; C E Hack; J H Smit; H C Comijs; P Eikelenboom
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

6.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.

Authors:  P M Ridker; M Cushman; M J Stampfer; R P Tracy; C H Hennekens
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

7.  Cognitive functioning in preclinical vascular dementia: a 6-year follow-up.

Authors:  Erika Jonsson Laukka; Sari Jones; Laura Fratiglioni; Lars Bäckman
Journal:  Stroke       Date:  2004-06-10       Impact factor: 7.914

8.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

9.  Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study.

Authors:  Reinhold Schmidt; Helena Schmidt; J David Curb; Kamal Masaki; Lon R White; Lenore J Launer
Journal:  Ann Neurol       Date:  2002-08       Impact factor: 10.422

10.  Predictors of cognitive decline and mortality of aged people over a 10-year period.

Authors:  Reijo S Tilvis; Mervi H Kähönen-Väre; Juha Jolkkonen; Jaakko Valvanne; Kaisu H Pitkala; Timo E Strandberg
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-03       Impact factor: 6.053

View more
  21 in total

1.  Correlates of Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Sarah R Gillett; Evan L Thacker; Abraham J Letter; Leslie A McClure; Virginia G Wadley; Frederick W Unverzagt; Brett M Kissela; Richard E Kennedy; Stephen P Glasser; Deborah A Levine; Mary Cushman
Journal:  Clin Neuropsychol       Date:  2015-05-15       Impact factor: 3.535

2.  Genetic effect of MTHFR C677T polymorphism on the structural covariance network and white-matter integrity in Alzheimer's disease.

Authors:  Yu-Tzu Chang; Shih-Wei Hsu; Shih-Jen Tsai; Ya-Ting Chang; Chi-Wei Huang; Mu-En Liu; Nai-Ching Chen; Wen-Neng Chang; Jung-Lung Hsu; Chen-Chang Lee; Chiung-Chih Chang
Journal:  Hum Brain Mapp       Date:  2017-03-25       Impact factor: 5.038

3.  Cardiac output, blood pressure variability, and cognitive decline in geriatric cardiac patients.

Authors:  Ozioma C Okonkwo; Ronald A Cohen; John Gunstad; Athena Poppas
Journal:  J Cardiopulm Rehabil Prev       Date:  2011 Sep-Oct       Impact factor: 2.081

4.  The protected survivor model: Using resistant successful cognitive aging to identify protection in the very old.

Authors:  Jeremy M Silverman; James Schmeidler
Journal:  Med Hypotheses       Date:  2017-10-31       Impact factor: 1.538

5.  C-reactive protein and familial risk for dementia: a phenotype for successful cognitive aging.

Authors:  Jeremy M Silverman; James Schmeidler; Michal S Beeri; Clive Rosendorff; Mary Sano; Hillel T Grossman; José R Carrión-Baralt; Irina N Bespalova; Rebecca West; Vahram Haroutunian
Journal:  Neurology       Date:  2012-08-15       Impact factor: 9.910

6.  Physical activity, obesity, and cognitive impairment among women with systemic lupus erythematosus.

Authors:  Patricia Katz; Laura Julian; Mary C Tonner; Jinoos Yazdany; Laura Trupin; Edward Yelin; Lindsey A Criswell
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-04       Impact factor: 4.794

7.  C-reactive protein is related to memory and medial temporal brain volume in older adults.

Authors:  Brianne Magouirk Bettcher; Reva Wilheim; Taylor Rigby; Ralph Green; Joshua W Miller; Caroline A Racine; Kristine Yaffe; Bruce L Miller; Joel H Kramer
Journal:  Brain Behav Immun       Date:  2011-08-06       Impact factor: 7.217

Review 8.  Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship.

Authors:  Brianne Magouirk Bettcher; Joel H Kramer
Journal:  Neurocase       Date:  2012-04-19       Impact factor: 0.881

9.  Longitudinal trajectories of cognitive decline among older adults with cardiovascular disease.

Authors:  Ozioma C Okonkwo; Ronald A Cohen; John Gunstad; Geoffrey Tremont; Michael L Alosco; Athena Poppas
Journal:  Cerebrovasc Dis       Date:  2010-08-05       Impact factor: 2.762

10.  Cognitive dysfunction with aging and the role of inflammation.

Authors:  Arthur A Simen; Kelly A Bordner; Mark P Martin; Lawrence A Moy; Lisa C Barry
Journal:  Ther Adv Chronic Dis       Date:  2011-05       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.